Expression and Functional Characterization of Human ABC Transporter ABCG2 Variants in Insect Cells
Hitherto three variant forms of ABCG2 have been documented on the basis of their amino acid moieties (i.e., Arg, Gly, and Thr) at the position 482. In the present study, we have generated those variants of ABCG2 by site-directed mutagenesis and expressed them in Sf9 insect cells. The apparent molecu...
Gespeichert in:
Veröffentlicht in: | DRUG METABOLISM AND PHARMACOKINETICS 2003, Vol.18 (3), p.194-202 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 202 |
---|---|
container_issue | 3 |
container_start_page | 194 |
container_title | DRUG METABOLISM AND PHARMACOKINETICS |
container_volume | 18 |
creator | Ishikawa, Toshihisa Kasamatsu, Shiho Hagiwara, Yuko Mitomo, Hideyuki Kato, Ryo Sumino, Yasuhiro |
description | Hitherto three variant forms of ABCG2 have been documented on the basis of their amino acid moieties (i.e., Arg, Gly, and Thr) at the position 482. In the present study, we have generated those variants of ABCG2 by site-directed mutagenesis and expressed them in Sf9 insect cells. The apparent molecular weight of the expressed ABCG2 variants was 130,000 under non-reductive conditions, whereas it was reduced to 65,000 by treatment with mercaptoethanol. It is suggested that ABCG2 exists in the plasma membrane of Sf9 cells as a homodimer bound through cysteinyl disulfide bond(s). Both ATPase activity and drug transport of ABCG2 variants were examined by using plasma membrane fractions prepared from ABCG2-overexpressing Sf9 cells. The ATPase activity of the plasma membrane expressing ABCG2 (Gly-482) was significantly enhanced by prazosin. In contrast, ABCG2 (Arg-482) transports [3H]methotrexate in an ATP-dependent manner; however, no transport activity was observed with the other variants (Gly-482 and Thr-482). It is strongly suggested that the amino acid moiety at the position of 482 is critical for the substrate specificity of ABCG2. |
doi_str_mv | 10.2133/dmpk.18.194 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_2133_dmpk_18_194</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S134743671530882X</els_id><sourcerecordid>S134743671530882X</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-d1ea800d07ebfb46e3be5aa34925ae7f64d7aa1c9b851d5f76556da9d4248ca73</originalsourceid><addsrcrecordid>eNptkEtP3DAURq2KqlBg1X3lPcrgd5wlRMyAhNQNsLVubEc1TZzIzqDCr8dhkLrp6r6OPtkHoR-UbBjl_NKN858N1RvaiC_ohGpNKtIwclR6LupKcFUfo-85PxPCuRTsGzqmUlFdc3mCupu_c_I5hyliiA5v99EuZYABt78hgV18Cm-wrvDU49v9CBFfXbf4IUHM85TKfZ13DD9BChCXjEPEdzF7u-DWD0M-Q197GLI__6yn6HF789DeVve_dnft1X1lJWFL5agHTYgjte_6TijPOy8BuGiYBF_3SrgagNqm05I62ddKSuWgcYIJbaHmp-jikGvTlHPyvZlTGCG9GkrMasqspgzVppgq9M8DPe-70bt_7KeaAmwPQLkGC8MUhxC9eZ72qdjJxk509At0hhWvhhCqP4o0pMQbwghTQimyBslDkC-ffwk-mWyDj7bEpiLJuCn894Xvh0uNtQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Expression and Functional Characterization of Human ABC Transporter ABCG2 Variants in Insect Cells</title><source>J-STAGE Free</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Ishikawa, Toshihisa ; Kasamatsu, Shiho ; Hagiwara, Yuko ; Mitomo, Hideyuki ; Kato, Ryo ; Sumino, Yasuhiro</creator><creatorcontrib>Ishikawa, Toshihisa ; Kasamatsu, Shiho ; Hagiwara, Yuko ; Mitomo, Hideyuki ; Kato, Ryo ; Sumino, Yasuhiro ; Tokyo Japan ; Takeda Chemical Industries ; Department of Biomolecular Engineering ; The Japan Pharmaceutical Manufacturer's Association (JPMA ; LTD ; Tokyo Institute of Technology ; Strategic Product Planning Department ; Graduate School of Bioscience and Biotechnology ; Pharma SNP Consortium ; Osaka ; Kanagawa ; Japan</creatorcontrib><description>Hitherto three variant forms of ABCG2 have been documented on the basis of their amino acid moieties (i.e., Arg, Gly, and Thr) at the position 482. In the present study, we have generated those variants of ABCG2 by site-directed mutagenesis and expressed them in Sf9 insect cells. The apparent molecular weight of the expressed ABCG2 variants was 130,000 under non-reductive conditions, whereas it was reduced to 65,000 by treatment with mercaptoethanol. It is suggested that ABCG2 exists in the plasma membrane of Sf9 cells as a homodimer bound through cysteinyl disulfide bond(s). Both ATPase activity and drug transport of ABCG2 variants were examined by using plasma membrane fractions prepared from ABCG2-overexpressing Sf9 cells. The ATPase activity of the plasma membrane expressing ABCG2 (Gly-482) was significantly enhanced by prazosin. In contrast, ABCG2 (Arg-482) transports [3H]methotrexate in an ATP-dependent manner; however, no transport activity was observed with the other variants (Gly-482 and Thr-482). It is strongly suggested that the amino acid moiety at the position of 482 is critical for the substrate specificity of ABCG2.</description><identifier>ISSN: 1347-4367</identifier><identifier>EISSN: 1880-0920</identifier><identifier>DOI: 10.2133/dmpk.18.194</identifier><identifier>PMID: 15618735</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>ABC transporter ; ABCG2 ; BCRP ; pharmacogenomics ; single nucleotide polymorphism</subject><ispartof>DRUG METABOLISM AND PHARMACOKINETICS, 2003, Vol.18 (3), p.194-202</ispartof><rights>2003 The Japanese Society for the Study of Xenobiotics</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-d1ea800d07ebfb46e3be5aa34925ae7f64d7aa1c9b851d5f76556da9d4248ca73</citedby><cites>FETCH-LOGICAL-c502t-d1ea800d07ebfb46e3be5aa34925ae7f64d7aa1c9b851d5f76556da9d4248ca73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15618735$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishikawa, Toshihisa</creatorcontrib><creatorcontrib>Kasamatsu, Shiho</creatorcontrib><creatorcontrib>Hagiwara, Yuko</creatorcontrib><creatorcontrib>Mitomo, Hideyuki</creatorcontrib><creatorcontrib>Kato, Ryo</creatorcontrib><creatorcontrib>Sumino, Yasuhiro</creatorcontrib><creatorcontrib>Tokyo Japan</creatorcontrib><creatorcontrib>Takeda Chemical Industries</creatorcontrib><creatorcontrib>Department of Biomolecular Engineering</creatorcontrib><creatorcontrib>The Japan Pharmaceutical Manufacturer's Association (JPMA</creatorcontrib><creatorcontrib>LTD</creatorcontrib><creatorcontrib>Tokyo Institute of Technology</creatorcontrib><creatorcontrib>Strategic Product Planning Department</creatorcontrib><creatorcontrib>Graduate School of Bioscience and Biotechnology</creatorcontrib><creatorcontrib>Pharma SNP Consortium</creatorcontrib><creatorcontrib>Osaka</creatorcontrib><creatorcontrib>Kanagawa</creatorcontrib><creatorcontrib>Japan</creatorcontrib><title>Expression and Functional Characterization of Human ABC Transporter ABCG2 Variants in Insect Cells</title><title>DRUG METABOLISM AND PHARMACOKINETICS</title><addtitle>Drug Metab Pharmacokinet</addtitle><description>Hitherto three variant forms of ABCG2 have been documented on the basis of their amino acid moieties (i.e., Arg, Gly, and Thr) at the position 482. In the present study, we have generated those variants of ABCG2 by site-directed mutagenesis and expressed them in Sf9 insect cells. The apparent molecular weight of the expressed ABCG2 variants was 130,000 under non-reductive conditions, whereas it was reduced to 65,000 by treatment with mercaptoethanol. It is suggested that ABCG2 exists in the plasma membrane of Sf9 cells as a homodimer bound through cysteinyl disulfide bond(s). Both ATPase activity and drug transport of ABCG2 variants were examined by using plasma membrane fractions prepared from ABCG2-overexpressing Sf9 cells. The ATPase activity of the plasma membrane expressing ABCG2 (Gly-482) was significantly enhanced by prazosin. In contrast, ABCG2 (Arg-482) transports [3H]methotrexate in an ATP-dependent manner; however, no transport activity was observed with the other variants (Gly-482 and Thr-482). It is strongly suggested that the amino acid moiety at the position of 482 is critical for the substrate specificity of ABCG2.</description><subject>ABC transporter</subject><subject>ABCG2</subject><subject>BCRP</subject><subject>pharmacogenomics</subject><subject>single nucleotide polymorphism</subject><issn>1347-4367</issn><issn>1880-0920</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNptkEtP3DAURq2KqlBg1X3lPcrgd5wlRMyAhNQNsLVubEc1TZzIzqDCr8dhkLrp6r6OPtkHoR-UbBjl_NKN858N1RvaiC_ohGpNKtIwclR6LupKcFUfo-85PxPCuRTsGzqmUlFdc3mCupu_c_I5hyliiA5v99EuZYABt78hgV18Cm-wrvDU49v9CBFfXbf4IUHM85TKfZ13DD9BChCXjEPEdzF7u-DWD0M-Q197GLI__6yn6HF789DeVve_dnft1X1lJWFL5agHTYgjte_6TijPOy8BuGiYBF_3SrgagNqm05I62ddKSuWgcYIJbaHmp-jikGvTlHPyvZlTGCG9GkrMasqspgzVppgq9M8DPe-70bt_7KeaAmwPQLkGC8MUhxC9eZ72qdjJxk509At0hhWvhhCqP4o0pMQbwghTQimyBslDkC-ffwk-mWyDj7bEpiLJuCn894Xvh0uNtQ</recordid><startdate>2003</startdate><enddate>2003</enddate><creator>Ishikawa, Toshihisa</creator><creator>Kasamatsu, Shiho</creator><creator>Hagiwara, Yuko</creator><creator>Mitomo, Hideyuki</creator><creator>Kato, Ryo</creator><creator>Sumino, Yasuhiro</creator><general>Elsevier Ltd</general><general>Japanese Society for the Study of Xenobiotics</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2003</creationdate><title>Expression and Functional Characterization of Human ABC Transporter ABCG2 Variants in Insect Cells</title><author>Ishikawa, Toshihisa ; Kasamatsu, Shiho ; Hagiwara, Yuko ; Mitomo, Hideyuki ; Kato, Ryo ; Sumino, Yasuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-d1ea800d07ebfb46e3be5aa34925ae7f64d7aa1c9b851d5f76556da9d4248ca73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>ABC transporter</topic><topic>ABCG2</topic><topic>BCRP</topic><topic>pharmacogenomics</topic><topic>single nucleotide polymorphism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishikawa, Toshihisa</creatorcontrib><creatorcontrib>Kasamatsu, Shiho</creatorcontrib><creatorcontrib>Hagiwara, Yuko</creatorcontrib><creatorcontrib>Mitomo, Hideyuki</creatorcontrib><creatorcontrib>Kato, Ryo</creatorcontrib><creatorcontrib>Sumino, Yasuhiro</creatorcontrib><creatorcontrib>Tokyo Japan</creatorcontrib><creatorcontrib>Takeda Chemical Industries</creatorcontrib><creatorcontrib>Department of Biomolecular Engineering</creatorcontrib><creatorcontrib>The Japan Pharmaceutical Manufacturer's Association (JPMA</creatorcontrib><creatorcontrib>LTD</creatorcontrib><creatorcontrib>Tokyo Institute of Technology</creatorcontrib><creatorcontrib>Strategic Product Planning Department</creatorcontrib><creatorcontrib>Graduate School of Bioscience and Biotechnology</creatorcontrib><creatorcontrib>Pharma SNP Consortium</creatorcontrib><creatorcontrib>Osaka</creatorcontrib><creatorcontrib>Kanagawa</creatorcontrib><creatorcontrib>Japan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>DRUG METABOLISM AND PHARMACOKINETICS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishikawa, Toshihisa</au><au>Kasamatsu, Shiho</au><au>Hagiwara, Yuko</au><au>Mitomo, Hideyuki</au><au>Kato, Ryo</au><au>Sumino, Yasuhiro</au><aucorp>Tokyo Japan</aucorp><aucorp>Takeda Chemical Industries</aucorp><aucorp>Department of Biomolecular Engineering</aucorp><aucorp>The Japan Pharmaceutical Manufacturer's Association (JPMA</aucorp><aucorp>LTD</aucorp><aucorp>Tokyo Institute of Technology</aucorp><aucorp>Strategic Product Planning Department</aucorp><aucorp>Graduate School of Bioscience and Biotechnology</aucorp><aucorp>Pharma SNP Consortium</aucorp><aucorp>Osaka</aucorp><aucorp>Kanagawa</aucorp><aucorp>Japan</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression and Functional Characterization of Human ABC Transporter ABCG2 Variants in Insect Cells</atitle><jtitle>DRUG METABOLISM AND PHARMACOKINETICS</jtitle><addtitle>Drug Metab Pharmacokinet</addtitle><date>2003</date><risdate>2003</risdate><volume>18</volume><issue>3</issue><spage>194</spage><epage>202</epage><pages>194-202</pages><issn>1347-4367</issn><eissn>1880-0920</eissn><abstract>Hitherto three variant forms of ABCG2 have been documented on the basis of their amino acid moieties (i.e., Arg, Gly, and Thr) at the position 482. In the present study, we have generated those variants of ABCG2 by site-directed mutagenesis and expressed them in Sf9 insect cells. The apparent molecular weight of the expressed ABCG2 variants was 130,000 under non-reductive conditions, whereas it was reduced to 65,000 by treatment with mercaptoethanol. It is suggested that ABCG2 exists in the plasma membrane of Sf9 cells as a homodimer bound through cysteinyl disulfide bond(s). Both ATPase activity and drug transport of ABCG2 variants were examined by using plasma membrane fractions prepared from ABCG2-overexpressing Sf9 cells. The ATPase activity of the plasma membrane expressing ABCG2 (Gly-482) was significantly enhanced by prazosin. In contrast, ABCG2 (Arg-482) transports [3H]methotrexate in an ATP-dependent manner; however, no transport activity was observed with the other variants (Gly-482 and Thr-482). It is strongly suggested that the amino acid moiety at the position of 482 is critical for the substrate specificity of ABCG2.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15618735</pmid><doi>10.2133/dmpk.18.194</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1347-4367 |
ispartof | DRUG METABOLISM AND PHARMACOKINETICS, 2003, Vol.18 (3), p.194-202 |
issn | 1347-4367 1880-0920 |
language | eng |
recordid | cdi_crossref_primary_10_2133_dmpk_18_194 |
source | J-STAGE Free; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | ABC transporter ABCG2 BCRP pharmacogenomics single nucleotide polymorphism |
title | Expression and Functional Characterization of Human ABC Transporter ABCG2 Variants in Insect Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A29%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20and%20Functional%20Characterization%20of%20Human%20ABC%20Transporter%20ABCG2%20Variants%20in%20Insect%20Cells&rft.jtitle=DRUG%20METABOLISM%20AND%20PHARMACOKINETICS&rft.au=Ishikawa,%20Toshihisa&rft.aucorp=Tokyo%20Japan&rft.date=2003&rft.volume=18&rft.issue=3&rft.spage=194&rft.epage=202&rft.pages=194-202&rft.issn=1347-4367&rft.eissn=1880-0920&rft_id=info:doi/10.2133/dmpk.18.194&rft_dat=%3Celsevier_cross%3ES134743671530882X%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15618735&rft_els_id=S134743671530882X&rfr_iscdi=true |